Flange extender
Latest BRISTOL-MYERS SQUIBB COMPANY Patents:
- Therapeutic immunoglobulin G4 for improved bioanalytical and bioprocessing properties
- Hepatitis C virus inhibitors
- UREA ANTAGONISTS OF P2Y1 RECEPTOR USEFUL IN THE TREATMENT OF THROMBOTIC CONDITIONS
- Six-membered heterocycles useful as serine protease inhibitors
- COMBINATION OF SRC KINASE INHIBITORS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
Description
The broken lines illustrate portions of the drawings that form no part of the claimed design.
Claims
The ornamental design for a flange extender, as shown and described.
Referenced Cited
U.S. Patent Documents
| 4981476 | January 1, 1991 | Aichlmayr |
| D449379 | October 16, 2001 | Fuhr |
| D576276 | September 2, 2008 | Osypka |
| D581044 | November 18, 2008 | Sudo |
| D581045 | November 18, 2008 | Sudo |
| D602158 | October 13, 2009 | Cuevas |
| D649241 | November 22, 2011 | Kunishige |
| D660418 | May 22, 2012 | Kuczek |
| D675317 | January 29, 2013 | Baxter |
| D702835 | April 15, 2014 | Vinchon |
| 8887729 | November 18, 2014 | Harrington |
| D751705 | March 15, 2016 | Hitscherich, Jr. |
| D757258 | May 24, 2016 | Weiβhaupt |
Patent History
Patent number: D802125
Type: Grant
Filed: Feb 2, 2017
Date of Patent: Nov 7, 2017
Assignee: BRISTOL-MYERS SQUIBB COMPANY (Princeton, NJ)
Inventors: Eric Schiller (Westfield, NJ), Christina Joy Laskar (Fort Lee, NJ), Mitali Aon (Martinsville, NJ), Richard Caizza (Union City, NJ), Jon Bell (Waldwick, NJ)
Primary Examiner: David Muller
Application Number: 29/592,765
Type: Grant
Filed: Feb 2, 2017
Date of Patent: Nov 7, 2017
Assignee: BRISTOL-MYERS SQUIBB COMPANY (Princeton, NJ)
Inventors: Eric Schiller (Westfield, NJ), Christina Joy Laskar (Fort Lee, NJ), Mitali Aon (Martinsville, NJ), Richard Caizza (Union City, NJ), Jon Bell (Waldwick, NJ)
Primary Examiner: David Muller
Application Number: 29/592,765
Classifications
Current U.S. Class:
Syringe, Catheter Or Needle Component (22) (D24/130)